VC
Netherlands
New Fund 2024

Forbion

Check Size
€5M – €50M

Investment Focus

Geographic Focus

Investment Thesis

One of Europe's leading life sciences and healthcare VCs with €5B+ AUM across venture and growth strategies. Invests in innovative biotech, medtech, and healthcare companies across Europe and the US.

How to Pitch Forbion

No Stated Policy
Forbion hasn't published an outreach policy. A short, specific cold email is the safest default.
Source

Portfolio Highlights

argenx - autoimmune therapies (early investor)
Merus - bispecific antibody oncology (Nasdaq-listed)
Pharvaris - hereditary angioedema therapies
Oxitope Pharma - cardiovascular inflammation
Forbion BioEconomy Fund I - €200M sustainable biotech fund (2025)
88% lead or co-lead rate on initial investments across recent funds
Calluna Pharma - immunology therapeutics
Mariana Oncology - radiopharmaceuticals
58 active investments across biotech and life sciences

Focus and check size from the firm's website. Website reachable as of Aug 2026.

Ready to Reach Forbion?

A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.